Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

News Conference News ISET 2023

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

Caitlin E. Cox

January 25, 2023

Podcast Rox Heart Radio

Rox Heart Radio: Barry Katzen

May 13, 2020

News Conference News ISET 2020

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

Caitlin E. Cox

February 05, 2020

News Conference News ISET 2020

Fluoroless Cath Promises Less Radiation, but the Tech Is Still Early

Caitlin E. Cox

January 22, 2020

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Conference News ISET 2019

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Caitlin E. Cox

January 31, 2019

News Conference News ISET 2019

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Caitlin E. Cox

January 28, 2019

News Conference News ISET 2018

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

Caitlin E. Cox

February 07, 2018

Presentation ISET 2018

Status of CREST-2: What Will It Tell Us and When

Presenter: Barry T. Katzen

February 04, 2018

Presentation TCT 2017

What Does ATTRACT Mean for Catheter-Directed Thrombolysis for DVT?

Presenter: Michael R. Jaff, Robert A. Lookstein, Barry T. Katzen

October 30, 2017

News Conference News ISET 2017

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Caitlin E. Cox

February 10, 2017

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Caitlin E. Cox

February 07, 2017

Presentation TCT 2016

Optimal Approach to Persistent Type II Endoleaks with Sac Expansion

Presenter: Peter A. Schneider, Barry T. Katzen

November 01, 2016

Presentation TCT 2016

Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR

Presenter: D. Christopher Metzger, Peter A. Schneider, Barry T. Katzen

November 01, 2016

Presentation TCT 2016

State of the Art Lecture: Limitations With Current EVAR Technology and What Lies Ahead

Presenter: Robert M. Bersin, Brian G. DeRubertis, Barry T. Katzen

October 30, 2016

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

News Conference News ISET 2016

Tumors, Bad Backs, and Cataracts: Interventional Physicians Face a Lifetime of Risk

Michael O'Riordan

February 09, 2016

News Daily News

在医疗保险人口中，EVAR的早期生存优势在3年后失去

July 23, 2015

Advertisement

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

Rox Heart Radio: Barry Katzen

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

Fluoroless Cath Promises Less Radiation, but the Tech Is Still Early

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

Status of CREST-2: What Will It Tell Us and When

What Does ATTRACT Mean for Catheter-Directed Thrombolysis for DVT?

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Optimal Approach to Persistent Type II Endoleaks with Sac Expansion

Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR

State of the Art Lecture: Limitations With Current EVAR Technology and What Lies Ahead

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Tumors, Bad Backs, and Cataracts: Interventional Physicians Face a Lifetime of Risk

在医疗保险人口中，EVAR的早期生存优势在3年后失去

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content